Terms: = Prostate cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Treatment
41 results:
1. Aberrant activated notch1 promotes prostate enlargement driven by androgen signaling via disrupting mitochondrial function in mouse.
Kang JW; He JP; Liu YN; Zhang Y; Song SS; Xu QX; Wei SW; Lu L; Meng XQ; Xu L; Guo B; Su RW
Cell Mol Life Sci; 2024 Mar; 81(1):155. PubMed ID: 38538986
[TBL] [Abstract] [Full Text] [Related]
2. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
Jin R; Forbes CM; Miller NL; Lafin J; Strand DW; Case T; Cates JM; Liu Q; Ramirez-Solano M; Mohler JL; Matusik RJ
Prostate; 2024 Apr; 84(5):441-459. PubMed ID: 38168866
[TBL] [Abstract] [Full Text] [Related]
3. prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons.
Hernandez KM; Venkat A; Elbers DC; Bihn JR; Brophy MT; Do NV; La J; Liu Q; Prokhorenkov A; Metoki-Shlubsky N; Sung FC; Paller CJ; Fillmore NR; Grossman RL
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 38050021
[TBL] [Abstract] [Full Text] [Related]
4. Drastic Synergy of Lovastatin and
Yao CJ; Chang CL; Hu MH; Liao CH; Lai GM; Chiou TJ; Ho HL; Kuo HC; Yang YY; Whang-Peng J; Chuang SE
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960146
[TBL] [Abstract] [Full Text] [Related]
5. Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells.
Casagrande N; Borghese C; Corona G; Aldinucci D; Altaf M; Sulaiman AAA; Isab AA; Ahmad S; Peedikakkal AMP
J Biol Inorg Chem; 2023 Dec; 28(8):751-766. PubMed ID: 37955736
[TBL] [Abstract] [Full Text] [Related]
6. Knocking down SOX2 overcomes the resistance of prostate cancer to castration via notch signaling.
Du Z; Chen X; Zhu P; Lv Q; Yong J; Gu J
Mol Biol Rep; 2023 Nov; 50(11):9007-9017. PubMed ID: 37716921
[TBL] [Abstract] [Full Text] [Related]
7. Baicalin Antagonizes prostate cancer Stemness via Inhibiting notch1/NF-κB Signaling Pathway.
Wu MH; Wu K; Zhu YB; Li DC; Yang H; Zeng H
Chin J Integr Med; 2023 Oct; 29(10):914-923. PubMed ID: 37357241
[TBL] [Abstract] [Full Text] [Related]
8. Inducing apoptosis by using microRNA in radio-resistant prostate cancer: an in-silico study with an in-vitro validation.
Darvish L; Bahreyni-Toossi MT; Aghaee-Bakhtiari SH; Firouzjaei AA; Amraee A; Tarighatnia A; Azimian H
Mol Biol Rep; 2023 Jul; 50(7):6063-6074. PubMed ID: 37294470
[TBL] [Abstract] [Full Text] [Related]
9. Hypocretin-1 suppresses malignant progression of glioblastoma cells through notch1 signaling pathway.
Huan R; Yue J; Lan J; Wang J; Cheng Y; Zhang J; Tan Y
Brain Res Bull; 2023 May; 196():46-58. PubMed ID: 36925051
[TBL] [Abstract] [Full Text] [Related]
10. Dependence on MUC1-C in Progression of Neuroendocrine prostate cancer.
Kufe D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835130
[TBL] [Abstract] [Full Text] [Related]
11. Antiandrogen abiraterone and docetaxel treatments affect notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells.
Soylu H; Kırca M; Avcı S; Ozpolat B; Ustunel I
Exp Mol Pathol; 2021 Apr; 119():104607. PubMed ID: 33482170
[TBL] [Abstract] [Full Text] [Related]
12. [Immunohistochemical study of Ki-67, p53 and notch1 expressions in prostate cancer of different grades].
Kudryavtsev GY; Kudryavtseva LV; Mikhaleva LM; Solovieva NA; Babichenko II
Arkh Patol; 2020; 82(5):42-49. PubMed ID: 33054031
[TBL] [Abstract] [Full Text] [Related]
13. The role of microRNA in cisplatin resistance or sensitivity.
Wang S; Li MY; Liu Y; Vlantis AC; Chan JY; Xue L; Hu BG; Yang S; Chen MX; Zhou S; Guo W; Zeng X; Qiu S; van Hasselt CA; Tong MC; Chen GG
Expert Opin Ther Targets; 2020 Sep; 24(9):885-897. PubMed ID: 32559147
[TBL] [Abstract] [Full Text] [Related]
14. Carvacrol Induced Program Cell Death and Cell Cycle Arrest in Androgen-Independent Human prostate cancer Cells
Khan F; Singh VK; Saeed M; Kausar MA; Ansari IA
Anticancer Agents Med Chem; 2019; 19(13):1588-1608. PubMed ID: 31364516
[TBL] [Abstract] [Full Text] [Related]
15. Estrogen receptor α-notch1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer.
Shen Y; Cao J; Liang Z; Lin Q; Wang J; Yang X; Zhang R; Zong J; Du X; Peng Y; Zhang J; Shi J
Cell Commun Signal; 2019 May; 17(1):50. PubMed ID: 31122254
[TBL] [Abstract] [Full Text] [Related]
16. Loss of notch1 Activity Inhibits prostate cancer Growth and Metastasis and Sensitizes prostate cancer Cells to Antiandrogen Therapies.
Rice MA; Hsu EC; Aslan M; Ghoochani A; Su A; Stoyanova T
Mol Cancer Ther; 2019 Jul; 18(7):1230-1242. PubMed ID: 31028097
[TBL] [Abstract] [Full Text] [Related]
17. NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells.
Farah E; Li C; Cheng L; Kong Y; Lanman NA; Pascuzzi P; Lorenz GR; Zhang Y; Ahmad N; Li L; Ratliff T; Liu X
J Biol Chem; 2019 May; 294(21):8543-8554. PubMed ID: 30940724
[TBL] [Abstract] [Full Text] [Related]
18. Ectopic expression of CC chemokine receptor 7 promotes prostate cancer cells metastasis via notch1 signaling.
Du R; Tang G; Tang Z; Kuang Y
J Cell Biochem; 2019 Jun; 120(6):9639-9647. PubMed ID: 30548287
[TBL] [Abstract] [Full Text] [Related]
19. MicroRNA-34a Attenuates Paclitaxel Resistance in prostate cancer Cells via Direct Suppression of JAG1/notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of PER3 reverses paclitaxel resistance of prostate cancer cells by inhibiting the Notch pathway.
Cai DW; Chen D; Sun SP; Liu ZJ; Liu F; Xian SZ; Wu PS; Kong GQ
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2572-2579. PubMed ID: 29771413
[TBL] [Abstract] [Full Text] [Related]
[Next]
